QuantumCyte, a Sunnyvale biotech founded in 2013, improves nucleic acid purity from tissue samples for genomic research.
Founded in 2013 by John Butler and based in Sunnyvale, California, QuantumCyte offers nucleic acid extraction services using its QPRECISE platform, which improves the signal-to-noise ratio in multi-omic applications. It serves oncology researchers and genomics professionals in North America and Europe, processing samples such as formalin-fixed, paraffin-embedded tissue. As of May 2017 it received seed funding led by SOSV, with participation from IndieBio.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in